Systematic review of 36 studies
Across a systematic review of 36 studies (35 preclinical, 1 clinical), BPC-157 is consistently reported in animal and preclinical models to accelerate healing of tendon, ligament, muscle, bone and gastrointestinal tissue, acting through angiogenic and cell-migration pathways. Independent human clinical evidence supporting the same effect is limited to a single small, uncontrolled retrospective case series.
- Study type
- Human observational
- Population
- Predominantly rodent tendon, ligament, muscle, bone and gastrointestinal-injury models; one human retrospective case series
- Source
- 1 Vasireddi et al., 2025
Limitation: The review is preclinical-heavy (35 of 36 included studies are animal models); the sole clinical study is retrospective, uncontrolled and unblinded.
Limitations in full
The review is preclinical-heavy (35 of 36 included studies are animal models); the sole clinical study is retrospective, uncontrolled and unblinded. No RCT or controlled human trial of any kind was identified. The evidence strength is rated Limited for these reasons.